Lifetime risk of dementia and Alzheimer's disease

痴呆 入射(几何) 累积发病率 医学 预期寿命 人口学 人口 纵向研究 阿尔茨海默病 终身风险 老年学 疾病 相对风险 风险因素 流行病学 儿科 置信区间 内科学 队列 环境卫生 病理 物理 社会学 光学
作者
Sudha Seshadri,P A Wolf,Alexa Beiser,Rhoda Au,K. McNulty,Robert J. White,Ralph B. D’Agostino
出处
期刊:Neurology [Ovid Technologies (Wolters Kluwer)]
卷期号:49 (6): 1498-1504 被引量:424
标识
DOI:10.1212/wnl.49.6.1498
摘要

We estimated the remaining lifetime risks of developing Alzheimer9s disease (AD) and dementia from all causes, based on data from longitudinal population studies. The risk of developing AD during one9s lifetime depends on both disease incidence and life expectancy. Conventional estimates of cumulative incidence overestimate the risk when there is a substantial probability of mortality due to competing causes. A total of 2,611 cognitively intact subjects (1,061 men, 1,550 women; mean age, 66± 7 years) were prospectively evaluated for the development of AD or other dementia. A modified survival analysis was used to estimate both cumulative incidence and the sex-specific remaining lifetime risk estimates for quinquennial age groups above age 65 years. Over a 20-year follow-up period, 198 subjects developed dementia (120 with AD). The remaining lifetime risk of AD or other dementia depended on sex, being higher in women, but varied little with age between 65 and 80 years. In a 65-year-old man, the remaining lifetime risk of AD was 6.3% (95% CI, 3.9 to 8.7) and the remaining lifetime risk of developing any dementing illness was 10.9% (95% CI, 8.0 to 13.8); corresponding risks for a 65-year-old woman were 12% (95% CI, 9.2 to 14.8) and 19% (95% CI, 17.2 to 22.5). The cumulative incidence between age 65 and 100 years was much higher: for AD, 25.5% in men and 28.1% in women; for dementia, 32.8% in men and 45% in women. The actual remaining lifetime risk of AD or dementia varies with age, sex, and life expectancy and is lower than the hypothetical risk estimated by a cumulative incidence in the same population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
游大侠完成签到,获得积分10
刚刚
深情安青应助xuening采纳,获得10
刚刚
刚刚
liu完成签到,获得积分10
刚刚
科研通AI6.1应助杨诗梦采纳,获得10
刚刚
Fighting发布了新的文献求助10
1秒前
LIn完成签到,获得积分10
1秒前
Xuan完成签到,获得积分10
1秒前
英俊的流沙关注了科研通微信公众号
2秒前
highlights完成签到,获得积分10
2秒前
晓世完成签到,获得积分10
2秒前
天天开心完成签到 ,获得积分10
2秒前
啊啊啊啊完成签到,获得积分10
2秒前
Hzw完成签到,获得积分10
3秒前
jm2025完成签到,获得积分10
3秒前
白蓝发布了新的文献求助10
3秒前
忐忑的远山完成签到,获得积分10
3秒前
尽落完成签到 ,获得积分10
3秒前
赛特特特完成签到,获得积分10
4秒前
zoey发布了新的文献求助30
4秒前
4秒前
江水边完成签到 ,获得积分10
5秒前
石头完成签到,获得积分10
5秒前
Bressanone完成签到,获得积分10
5秒前
5秒前
欣慰的雨旋完成签到 ,获得积分10
5秒前
张乐完成签到,获得积分20
6秒前
XuanWayne发布了新的文献求助10
6秒前
丹dan完成签到,获得积分10
6秒前
6秒前
粗心的沉鱼完成签到,获得积分10
6秒前
刘汉淼完成签到,获得积分0
6秒前
www完成签到 ,获得积分10
6秒前
Jenny完成签到 ,获得积分10
6秒前
自信132完成签到,获得积分10
7秒前
li完成签到,获得积分10
7秒前
Dengolia完成签到,获得积分10
7秒前
打打应助aha采纳,获得10
8秒前
8秒前
橙汁完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Relation between chemical structure and local anesthetic action: tertiary alkylamine derivatives of diphenylhydantoin 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6067010
求助须知:如何正确求助?哪些是违规求助? 7899200
关于积分的说明 16324856
捐赠科研通 5208880
什么是DOI,文献DOI怎么找? 2786325
邀请新用户注册赠送积分活动 1769111
关于科研通互助平台的介绍 1647835